Ensysce Biosciences, Inc.
ENSC
Revenue
181.80k
▼-123.93k▼-40.54%
3 Months ChangeAssets
2.80M
▼-2.28M▼-44.91%
3 Months ChangeLiabilities
1.32M
▼-337.33k▼-20.40%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-18
Form 8-K
ID: 0001493152-24-041589
2024-08-30
Form 8-K
ID: 0001493152-24-034451
2024-08-23
Form 8-K
ID: 0001493152-24-033731
2024-08-14
Form 8-K
ID: 0001493152-24-032272
2024-08-14
Form 10-Q
ID: 0001493152-24-032263
2024-05-28
Form 8-K
ID: 0001493152-24-021456
2024-05-13
Form 8-K
ID: 0001493152-24-018793
2024-05-13
Form 10-Q
ID: 0001493152-24-018718
2024-05-09
Form 8-K
ID: 0001493152-24-018482
2024-03-29
Form 8-K
ID: 0001493152-24-011871